Oncology

Rice University researchers tested CRISPR to cure sickle cell, now preparing for upcoming challenges A team of Researchers led by Rice University has recently tested CRISPR to correct the sickle cell mutation in up to 40% of the total stem cell samples taken from affected patients. Although the results are quite promising, it also highlights the challenges that must be cleared before the gene editing therapy can become a reliable and effective option for patients with blood disorders. FDA rejected the Apricus Biosciences’ erectile dysfunction cream for the second time For the second time, FDA has issued a complete response letter and rejected the Apricus Biosciences’ h...